The Melting Pot

[Ecomike]

If you all have not yet run across $MILV and the DD, here is small sample of of the story for the Melting Pot!

First of all MILV is custodial play, 290 Mil share, now locked float
No debt, and has already made 2 SEC fillings, after 11 years of silence and has 2 firms doing 11 years of audited SEC filings.

Here is where we put most of the MILV DD, and it is updated regularly:

https://ccabiotech.blogspot.com/p/patent.html

My latest read I have is that they will start with a new kind of non toxic Vitamin E-phosphate explained in the patent, that can be carried safely to the liver in a store bought drink like Monster drinks, where it can detoxify drugs that are currently too toxic to the liver to use, but that could, if they were safe for the liver be used to solve illnesses like Alzheimers. It can also detoxify alcohol!

It can also be used for organ transplants to preserve organs longer like the liver, heart, kidney, and so on.

One manager of the company, James Hovis, awho is the largest shareholder of the firm that is R/M with MILV had a drink line sold through the Coke company ages ago, and later started and sold another drink company, Aquiss that was selling its drinks at 450 7-11 stores in its early days.

The inventor, Dr. Michael W Fountain, had earlier versions of Liposomes and Liposome patents and was part of The Liposome Company that was bought in 2000 by Elan Pharma for 585 Million dollars in 2000.

Dr. Fountain currently has 131 issued patents, over 180 products sold world wide based on his patents, and a 28 page resume that includes about 7 drug companies, NATO, US DOD, and host of others that must include 100+ organizations, Gov agencies and businesses. His 28 page CV-resume is online.

The other version of what they have may be destined for drug trials as transport mechanisms that can cross the BBB-Blood Brain Barrier and repair TBI-Traumatic Brain Injury. Think NFL sports injuries since once of the major shareholders is Larry Kubin, a 2 time Superbowl champion who was recently a co-keynote speaker with the head of UPennMed center CBIR-Center for Brain Injury Research, at the annual UPennMed-TBI annual conference.

UPennMed has 1031 patent applications pending/filled last year and one of the major shareholders, Mathias, sits on the UPennMed Trust fund as a trustee-director, and was a founder, director and is still a consultant to the Carlyl group that has over 200 billion dollars of investment funds it manages.

I see a major Biotech birth underway and an immediate drink line with revenue and profits coming to MILVille. A drink line like no other we have ever seen.